Skip to content
10-Q

Quarterly Report

JOUNCE THERAPEUTICS, INC.

0001640455-22-000089

← back to feed
Filed
Aug 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 29, 2022 51.69M sh
Shares Diluted Q2 2022 · Jun 30, 2022 51.68M sh
Shares Diluted Q2 2022 · Jun 30, 2022 51.66M sh
Shares Diluted Q2 2022 · Jun 30, 2021 51.21M sh
Shares Diluted Q2 2022 · Jun 30, 2021 48.6M sh
Capex Q2 2022 · Jun 30, 2022 $456K
Capex Q2 2022 · Jun 30, 2021 $157K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$56.57M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$58.46M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $77.74M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $95.53M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $140.81M
Cash And Equivalents Q2 2022 · Dec 31, 2020 $147.49M
Stockholders Equity Q2 2022 · Jun 30, 2022 $157.73M
Stockholders Equity Q2 2022 · Mar 31, 2022 $188.96M
Stockholders Equity Q2 2022 · Dec 31, 2021 $223.81M
Stockholders Equity Q2 2022 · Jun 30, 2021 $278.46M
Stockholders Equity Q2 2022 · Mar 31, 2021 $279.45M
Stockholders Equity Q2 2022 · Dec 31, 2020 $211.29M
Current Liabilities Q2 2022 · Jun 30, 2022 $23.2M
Current Liabilities Q2 2022 · Dec 31, 2021 $18.9M
Total Liabilities Q2 2022 · Jun 30, 2022 $31.17M
Total Liabilities Q2 2022 · Dec 31, 2021 $28.89M
Current Assets Q2 2022 · Jun 30, 2022 $157.35M
Current Assets Q2 2022 · Dec 31, 2021 $190.83M
Total Assets Q2 2022 · Jun 30, 2022 $188.9M
Total Assets Q2 2022 · Dec 31, 2021 $252.7M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.65
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.37
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.08
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.63
Eps Basic Q2 2022 · Jun 30, 2022 −$0.65
Eps Basic Q2 2022 · Jun 30, 2022 −$1.37
Eps Basic Q2 2022 · Jun 30, 2021 −$0.08
Eps Basic Q2 2022 · Jun 30, 2021 −$0.63
Sga Expense Q2 2022 · Jun 30, 2022 $7.51M
Sga Expense Q2 2022 · Jun 30, 2022 $14.86M
Sga Expense Q2 2022 · Jun 30, 2021 $7.32M
Sga Expense Q2 2022 · Jun 30, 2021 $14.93M
Rd Expense Q2 2022 · Jun 30, 2022 $26.2M
Rd Expense Q2 2022 · Jun 30, 2022 $56.32M
Rd Expense Q2 2022 · Jun 30, 2021 $22.1M
Rd Expense Q2 2022 · Jun 30, 2021 $42.61M
Net Income Q2 2022 · Jun 30, 2022 −$33.51M
Net Income Q2 2022 · Jun 30, 2022 −$70.88M
Net Income Q2 2022 · Mar 31, 2022 −$37.37M
Net Income Q2 2022 · Jun 30, 2021 −$4.01M
Net Income Q2 2022 · Jun 30, 2021 −$30.55M
Net Income Q2 2022 · Mar 31, 2021 −$26.54M
Operating Income Q2 2022 · Jun 30, 2022 −$33.71M
Operating Income Q2 2022 · Jun 30, 2022 −$71.18M
Operating Income Q2 2022 · Jun 30, 2021 −$4.05M
Operating Income Q2 2022 · Jun 30, 2021 −$30.63M